Illinois Upheld a $45 Million Talc Verdict Against Johnson & Johnson — What It Means for Your Family
You are reading this because someone you love used talcum powder — maybe for years, maybe for decades — and then the diagnosis came. Ovarian cancer. Mesothelioma. A cancer that felt like it came from nowhere until you started searching and found out that nowhere might have been the bathroom shelf the whole time. And now you have seen the headline: an Illinois appellate court just upheld a $45 million verdict against Johnson & Johnson, and the court refused to reduce it. We are writing this page for you — the person at the kitchen table at 2 a.m. wondering whether the law has a door still open for your family, and how long that door stays open before it closes.
We are Attorney911 — The Manginello Law Firm. We are a trial firm that takes toxic tort cases and fights the companies that put dangerous products into the hands of people who trusted them. The $45 million verdict that just survived appeal in Illinois is not our case — we were not counsel on it, and we do not claim to have been. But we know what that ruling means, we know the law that produced it, and we know what Johnson & Johnson will do next to try to keep families like yours out of a courtroom. That knowledge is what we give you here, freely, because the first thing a family in your position needs is the truth about what they are standing in.
What Just Happened in Illinois — and Why It Matters to Your Case
The Illinois Appellate Court upheld a $45 million verdict against Johnson & Johnson in a talc-related product liability case. The appellate court affirmed the original jury’s finding rather than reducing or overturning the award. In plain English: a group of Illinois citizens listened to the evidence, decided Johnson & Johnson was responsible for the harm done to the plaintiff, and put a $45 million price on it — and when the company appealed, a panel of appellate judges said the jury got it right and the number stands.
This matters to you for three reasons, and each one is concrete.
First, an appellate affirmance is not a news headline that fades. It is a legal precedent that other courts respect. When a trial verdict hits the wire, a company can dismiss it as a single jury’s mistake. When an appellate court upholds that verdict without reduction, the message to every other court — and to every defense lawyer calculating settlement value — is that this kind of case, with this kind of evidence, produces verdicts that survive review. That changes the math for every pending talc claim and every claim not yet filed.
Second, the Illinois appellate court’s refusal to reduce the verdict is significant because appellate courts in some states routinely cut jury awards — sometimes by half or more — under a doctrine called remittitur. The Illinois court did not do that here. The full $45 million survived. That tells you something about Illinois as a forum for these cases: the intermediate appellate review in this state will not reflexively compromise large tort verdicts, and that posture materially affects settlement leverage across the national talc docket.
Third, this ruling emerged amid thousands of pending talc claims nationwide. More than 68,000 talc cases are consolidated in a federal multidistrict litigation in New Jersey — MDL-2738 — before Judge Michael A. Shipp, as of June 2026. The Illinois verdict is a state-court result, separate from the federal MDL, and it proves that state courts and state juries can deliver and sustain substantial verdicts independently of the federal consolidation. For a family deciding where to file and what to expect, that independence matters.
Who Can File a Talc Lawsuit — and What Cancers Qualify
The cancers most consistently linked to talc exposure in the litigation and the scientific literature are ovarian cancer and mesothelioma. These are two very different diseases with two very different causal pathways, and understanding which one applies to your family changes the evidence your case needs.
Ovarian cancer is the injury most associated with perineal (genital) use of talcum powder — the product applied to the body for personal hygiene, sometimes for decades. The causal theory is that talc particles, applied near the vaginal opening, migrate through the reproductive tract to the ovaries, where they cause chronic inflammation and cellular damage that can develop into cancer over years. The latency period — the time between exposure and diagnosis — can be decades. A woman who used talc products in her twenties may not receive an ovarian cancer diagnosis until her fifties or sixties.
Mesothelioma is a cancer of the lining of the lungs or, less commonly, the abdomen, and it is essentially signature to asbestos exposure. The causal theory in talc cases is that some talc products were contaminated with asbestos — a mineral that often forms in the same geological deposits as talc — and that the asbestos fibers were inhaled or ingested when the powder was applied. Mesothelioma has an even longer latency period, typically 20 to 50 years, with most cases appearing 30 to 40 years after exposure. The disease is almost exclusively caused by asbestos, which makes the causal link powerful when asbestos contamination can be shown.
If your loved one was diagnosed with either of these cancers and had a history of using Johnson & Johnson talc products — Johnson’s Baby Powder, Shower to Shower, or similar products — the connection is worth examining with a lawyer who understands the specific evidence requirements for each disease. Not every cancer is talc-related, and not every talc user develops cancer. But the intersection of documented product use and a qualifying diagnosis is where a case begins.
Other cancers have been studied in connection with talc exposure, including endometrial cancer and certain respiratory cancers. The scientific evidence for these is less established than for ovarian cancer and mesothelioma, and the litigation landscape reflects that difference. If your diagnosis falls outside the two primary categories, the question of whether a viable claim exists turns on the strength of the specific scientific evidence — a question that requires individualized evaluation.
The Defendant: Johnson & Johnson’s Corporate Structure and Three Failed Bankruptcies
Johnson & Johnson is one of the largest healthcare companies in the world. It is also a company that has spent years engineering a corporate structure designed to wall off talc liability from the balance sheet that funds the company. Understanding this structure is not academic — it is the difference between naming the right defendant and watching your case get dismissed against an empty shell.
The parent company is Johnson & Johnson, the household name. The entity that historically manufactured and sold the talc products is Johnson & Johnson Consumer Inc. (JJCI). But the talc liability has been shuffled through a chain of entities that exist for one purpose: to contain the lawsuits.
LTL Management LLC was the entity created through a corporate maneuver called a “divisional merger” — sometimes called the “Texas two-step” — in which a company splits into two entities: one that keeps the valuable business and one that absorbs the liability. LTL Management was the liability entity, and it filed for Chapter 11 bankruptcy not once but twice. Both attempts were dismissed by the courts.
Red River Talc LLC was the renamed successor entity used for the third bankruptcy attempt. On March 31, 2025, the U.S. Bankruptcy Court for the Southern District of Texas — Judge Christopher Lopez presiding — denied confirmation and dismissed Red River Talc’s prepackaged Chapter 11. The court found vote-solicitation irregularities and impermissible nonconsensual third-party releases. This was Johnson & Johnson’s third failed bankruptcy bid. Three times the company tried to wall these cases off inside a bankruptcy it created on purpose; three times a court threw it out. The cases are back in the regular court system — the tort system — where juries, not bankruptcy judges, decide what the harm is worth.
Kenvue Inc. is the consumer-health spinoff from Johnson & Johnson — the company that now owns brands like Band-Aid, Tylenol, and Listerine. Johnson & Johnson has indemnity arrangements with Kenvue, but Kenvue is a separate publicly traded company. The corporate relationship between J&J and Kenvue, and the allocation of talc liability between them, is something that must be confirmed in any individual case.
What this means for you is straightforward: the company on the powder bottle and the company you actually sue may not be the same entity. Naming the wrong defendant — or failing to name all the right ones — can sink a case before the evidence is ever heard. A lawyer who understands the J&J corporate structure knows to identify the operating entity, the liability vehicle, the parent, and any successor or spinoff entities whose conduct or indemnity obligations are relevant.
Illinois Law: Why This State Is Different for Talc Cases
Illinois has emerged as a significant venue for talc product liability litigation, and the $45 million appellate affirmance is not an accident of geography. Several features of Illinois law make this state a forum where talc cases can succeed — and where the defense cannot rely on the procedural shortcuts available in other jurisdictions.
No Statutory Damage Caps
Illinois does not impose statutory caps on compensatory or punitive damages in product liability actions. Illinois courts have historically struck down damage cap legislation on constitutional grounds. This is not a technicality. In many states, a jury can return a $45 million verdict and a statute immediately reduces it to a fraction of that amount — a cap on non-economic damages, a cap on punitive damages, or both. Illinois does not do that. The full weight of the jury’s decision survives. When the Illinois Appellate Court affirmed the $45 million verdict without reduction, it was confirming what Illinois law already allows: the jury decides what the harm is worth, and the court does not second-guess that number by statute.
The punitive damages standard in Illinois requires clear and convincing evidence of willful and wanton conduct, and courts have upheld substantial punitive awards in product liability cases where corporate concealment is proven.
That standard — “clear and convincing evidence of willful and wanton conduct” — is the door to punitive damages in Illinois. In talc cases, the evidence that Johnson & Johnson possessed internal knowledge of asbestos contamination in its talc products over decades and chose not to warn consumers is the evidence that satisfies this standard. Internal corporate documents discovered in talc litigation have historically shown J&J was aware of asbestos contamination findings in its talc while publicly representing the product as safe. When a jury sees that evidence, it can award punitive damages on top of compensatory damages — and in Illinois, those punitive damages are not capped.
Modified Comparative Negligence with a 51 Percent Bar
Illinois applies a modified comparative negligence system with a 51 percent bar. This means a plaintiff cannot recover if found more than 50 percent at fault, but can recover with damages reduced by their percentage of fault if they are 50 percent or less at fault. In practice, the defense in talc cases rarely argues that the plaintiff was at fault for using the product — the product was marketed as safe for daily personal hygiene use, and consumers relied on that marketing. The comparative negligence rule matters more in cases where the defense tries to attribute fault to the plaintiff’s other risk factors or choices, but the 51 percent bar means the defense has to prove the plaintiff was primarily responsible — a heavy burden in a failure-to-warn case where the company knew the risk and said nothing.
The Discovery Rule and the Statute of Limitations
Illinois benefits from the discovery rule for statute of limitations purposes in toxic tort cases. This means the clock does not necessarily start running from the date of exposure — which in talc cases could have been decades ago — but from the date the plaintiff knew or reasonably should have known of the injury and its causal connection to the product. Illinois’s statute of limitations for personal injury claims is generally two years, and the wrongful death limitation is similarly two years from the date of death. But the discovery rule can mean that a woman diagnosed with ovarian cancer in 2024 who only learned in 2025 that her decades of talc use may have caused it may have a claim that is still within the limitations period — even though the exposure ended years ago.
This is one of the most important pieces of information on this page, and we want to state it plainly: if you are reading this and thinking “it has been too long,” you may be wrong. The discovery rule exists precisely because diseases like ovarian cancer and mesothelioma hide for decades, and the law recognizes that a person cannot sue over a connection they did not know existed. The question is not when the exposure happened — it is when you knew, or should have known, that the exposure caused the disease. That question is state-specific and fact-specific, and it is one of the first things we evaluate when a family calls.
Illinois Venue: Cook County and Madison County
Illinois trial courts, particularly in Cook County and the Madison County circuit, have historically hosted substantial toxic tort dockets and have produced plaintiff-favorable verdicts in pharmaceutical and product liability mass torts. The Illinois Appellate Court’s decision to affirm the $45 million verdict without reduction signals that intermediate appellate review in this state will not reflexively compromise large tort verdicts. Illinois venue dynamics — including urban jury pools with demographics that tend to be receptive to plaintiff product liability arguments — have made the state an attractive forum for toxic tort plaintiffs nationally.
The practical implication: if you live in Illinois and used talc products and developed a qualifying cancer, you may be able to file in an Illinois state court — a forum where juries have shown they will hold corporations accountable, and where appellate courts have shown they will let those verdicts stand.
The Evidence Clock: What Records Exist and How Fast They Disappear
Talc litigation is built on four categories of evidence, and each one has a clock. Some of those clocks are long — the internal corporate documents produced in the national MDL are largely preserved. Others are brutally short, and the evidence that ties your specific case to the product is the evidence most at risk.
Internal Johnson & Johnson Corporate Documents
Internal J&J corporate documents regarding talc testing, asbestos detection, and safety evaluations are the backbone of the knowledge element for failure-to-warn and fraudulent concealment theories. These documents prove what the company knew and when — and they support punitive damages by showing awareness of risk and deliberate non-disclosure. Much of this documentary evidence has already been produced in MDL discovery, making it available to cases filed anywhere. But case-specific documents and additional internal communications remain discoverable, and the full document set is vast. The MDL has been running since 2017, and the document production covers decades of corporate testing, internal communications, and safety evaluations.
Your Product Usage History — The Most Time-Sensitive Evidence
This is where urgency matters most. The evidence that links you or your loved one specifically to Johnson & Johnson talc products — the receipts, the containers, the witness statements from family members who saw the product used daily for years — is the evidence that fades fastest. Witnesses age. Memories blur. Product containers get thrown out during estate cleanouts or moves. A bathroom shelf that held the same bottle of Johnson’s Baby Powder for twenty years can be emptied in an afternoon by a family that does not know it was evidence.
If you are reading this and your loved one is still alive, or recently passed, the single most important immediate step is to document the product usage history. Write down the brand names, the frequency of use, the years of use, where the product was purchased, and who can testify to seeing it used. Photograph any containers that still exist. Do not assume that because the product is no longer on the shelf, the proof is gone — the container in the cabinet is proof, and so is the sister who remembers watching her mother dust herself with baby powder every morning for thirty years.
Pathology and Tissue Analysis
For mesothelioma cases in particular, pathology and tissue analysis can provide forensic evidence of asbestos fiber exposure in the plaintiff’s tissue. This is not a standard test — it requires preservation of tissue samples and analysis by qualified forensic pathologists using transmission electron microscopy (TEM), a specialized technique that can identify and count asbestos fibers at the individual level. Tissue samples must be preserved and analyzed promptly. If a loved one has passed, the pathology blocks and slides from biopsy or autopsy may still exist at the hospital or medical examiner’s office, but they are subject to that facility’s retention policy — and those policies vary.
For ovarian cancer cases, the tissue analysis is different — the causal connection is built through exposure history and epidemiological evidence rather than fiber detection in tissue. But the pathology records confirming the specific type and stage of cancer are essential to the damages case.
Medical Records Documenting Diagnosis and Treatment
Medical records documenting the diagnosis, treatment history, and alternative risk factor assessment are essential. They establish the injury element and screen for confounding causes that defense experts will use to challenge specific causation. Ongoing medical treatment generates records continuously, but early-period records and the diagnostic workup are most critical for causation — they capture the initial presentation, the differential diagnosis, and the physician’s assessment of risk factors, all of which frame the causal question.
The medical records also matter for damages. The cost of treatment, the progression of the disease, the impact on quality of life — all of this is documented in the medical record, and all of it feeds the life-care plan and the damages calculation that a jury ultimately sees.
The Medicine: What Talc Does to the Body
We are not doctors. But we build cases with doctors — oncologists, gynecologic oncologists, pathologists, toxicologists, epidemiologists — and we understand the medicine well enough to tell you what the evidence shows and what the defense will challenge.
Ovarian Cancer and Talc
The causal theory connecting talc to ovarian cancer is based on the migration of talc particles from the perineal area through the reproductive tract to the ovaries, where the particles cause chronic inflammation and cellular changes that can lead to cancer over time. The International Agency for Research on Cancer has classified perineal use of talc-based body powder as “possibly carcinogenic to humans” (Group 2B). Multiple epidemiological studies have examined the association between talc use and ovarian cancer, with some finding a modestly elevated risk, particularly with long-term and frequent use.
The proof problem the defense exploits in ovarian cancer cases is that ovarian cancer has many known risk factors — genetic mutations (BRCA1 and BRCA2), family history, hormone replacement therapy, nulliparity (never having given birth), endometriosis, and others. The defense argues that the cancer was caused by one of these alternative factors, not by talc. The counter is built from the exposure history: a woman with no genetic risk factors, no family history, who used talc products daily for decades, presents a causal picture that is hard to explain away. The epidemiological evidence — the studies showing elevated risk in long-term users — supports the general causation, and the individual exposure history supports the specific causation.
Mesothelioma and Asbestos-Contaminated Talc
Mesothelioma is different. It is a cancer of the mesothelial lining — most commonly the pleura (the lining of the lungs) — and it is essentially signature to asbestos exposure. The causal connection is so strong that mesothelioma itself is treated as near-conclusive evidence of asbestos exposure. In talc cases, the theory is that the talc product was contaminated with asbestos fibers — which can happen because talc and asbestos form in the same geological conditions — and that those fibers were inhaled during product use.
The defense in mesothelioma-talc cases does not usually argue that mesothelioma was caused by something other than asbestos (because it almost never is). Instead, the defense argues that the asbestos exposure came from a different source — an occupational exposure, a household exposure, a environmental exposure — not from the talc product. The counter is built from the exposure history (no known occupational asbestos exposure), the product testing (asbestos fibers found in the specific product or in similar products from the same mine or manufacturing process), and, where available, the tissue analysis showing the type and characteristics of asbestos fibers consistent with the talc product.
Mesothelioma has a long latency — typically 30 to 40 years between first exposure and diagnosis. A person exposed to asbestos-contaminated talc in their twenties may not develop mesothelioma until their sixties. This long latency is why the discovery rule matters so much: a person diagnosed in 2025 may have been exposed in 1985, and the connection between the exposure and the disease may not have been apparent until the diagnosis itself.
The Cost of These Diseases
Ovarian cancer treatment involves surgery (often total hysterectomy with debulking), chemotherapy, and in some cases targeted therapy or immunotherapy. The medical costs run into the hundreds of thousands of dollars for initial treatment alone, and ongoing surveillance, recurrence treatment, and management of treatment side effects can extend costs over years. For advanced-stage ovarian cancer, the five-year survival rate is sobering, and the disease often recurs.
Mesothelioma is even more devastating. Median survival from diagnosis is typically 12 to 21 months, even with aggressive treatment. Treatment may include surgery (pleurectomy/decortication or extrapleural pneumonectomy), chemotherapy, immunotherapy, radiation, and palliative care. The medical costs are enormous — often exceeding several hundred thousand dollars — and the disease is almost invariably fatal. In a wrongful death case, the damages include the medical costs incurred before death, the conscious pain and suffering experienced, and the family’s loss of financial support, companionship, and society.
The Money: What Talc Cases Are Worth
The $45 million verdict upheld by the Illinois Appellate Court is a concrete data point for case valuation in this state. It establishes that an Illinois jury, hearing a talc case with proven causation and corporate concealment evidence, can return a substantial verdict — and that an Illinois appellate court will let it stand.
Case Value Range
Cases with strong exposure histories, confirmed qualifying diagnoses (ovarian cancer or mesothelioma), and internal document support showing corporate knowledge of the risk could reasonably fall in a range from the low millions to tens of millions or more, depending on the severity of the injury, the strength of the evidence, the venue, and the punitive damages posture. The $45 million Illinois verdict sits near the upper end of what individual talc verdicts have produced nationally. The affirmed Ingham verdict in Missouri — originally $4.69 billion for 22 plaintiffs, reduced to approximately $2.12 billion by the Missouri Court of Appeals and affirmed when the U.S. Supreme Court denied certiorari in June 2021 — is the largest talc verdict to survive appellate review, though it involved multiple plaintiffs.
Not every case is worth $45 million. Deflators include causation defense challenges around dose and duration of talc exposure, competing risk factors for the plaintiff’s disease, the reality that not all talc cases achieve the same evidentiary strength, and Johnson & Johnson’s litigation strategy creating procedural delays. A case with a weaker exposure history, a diagnosis with strong alternative explanations, or a less favorable venue will be worth less than a case with decades of documented daily product use, a clean medical history absent other risk factors, and strong internal documents showing corporate concealment.
No Caps in Illinois
The absence of damage caps in Illinois means the full value of the harm — compensatory and punitive — can be placed before a jury. In states that cap non-economic damages, a catastrophic injury case can be artificially limited to the economic losses plus a capped amount for pain and suffering. Illinois does not do this. The jury hears the full picture and decides the full number.
Collectibility
The collectibility factor in talc cases against Johnson & Johnson is exceptionally strong. Johnson & Johnson is one of the largest companies in the world, with a balance sheet that can satisfy substantial verdicts. Unlike cases against thinly capitalized defendants where a large verdict is a paper victory, a verdict against J&J is a real recovery — if you can get to it past the corporate structure and the bankruptcy strategy. The three failed bankruptcy attempts were designed to prevent families from reaching the company’s assets; all three failed, and the cases are back in the tort system where the company’s resources are reachable.
How the Number Is Built
A real damages number in a talc case is not a single figure pulled from a verdict report. It is built from multiple components, each with its own evidentiary foundation:
Economic damages include past and future medical expenses, lost wages, and lost earning capacity. For a woman who underwent surgery and chemotherapy for ovarian cancer and was unable to work during treatment and recovery, the medical bills and lost income are documented in records and payroll statements. For a mesothelioma patient who died, the estate can recover the medical expenses incurred before death and the lost earning capacity projected across the years the person would have worked.
Non-economic damages include pain and suffering, emotional distress, loss of normal life, and, in Illinois, loss of society and companionship. These are the human losses that no receipt can measure — the fear of a terminal diagnosis, the physical pain of treatment, the loss of the life the person was supposed to live. In Illinois, these are not capped.
Punitive damages are available where the plaintiff proves by clear and convincing evidence that the defendant acted with willful and wanton conduct — essentially, that the company knew of the danger and chose to ignore it. In talc cases, the internal corporate documents showing knowledge of asbestos contamination and a deliberate decision not to warn consumers are the evidence that supports punitive damages. The purpose of punitive damages is not to compensate the plaintiff but to punish the defendant and deter similar conduct — and in a case where a company sold a product for decades while allegedly knowing it contained a carcinogen, the punitive exposure can be substantial.
The Defense Playbook: What Johnson & Johnson Will Do
Johnson & Johnson retains some of the most sophisticated defense lawyers in the country. They are not going to concede. Understanding their playbook is not paranoia — it is preparation.
Play 1: The Bankruptcy Shuffle
Johnson & Johnson has already attempted to channel all talc liability into a bankruptcy entity three times — through LTL Management LLC and then Red River Talc LLC — using a corporate maneuver designed to wall off the liability from the company’s assets. All three attempts failed. The courts found vote-solicitation irregularities and impermissible nonconsensual third-party releases. But the strategy itself tells you something: this is a company that would rather fight in bankruptcy court than in front of juries. The reason is simple — juries hold companies accountable; bankruptcy judges divide assets on a schedule. The counter to this play is persistence: the courts have rejected the bankruptcy strategy, and the cases are back in the tort system. Each failed bankruptcy attempt is itself evidence of a company trying to avoid jury accountability.
Play 2: Causation Attack — “It Wasn’t the Powder”
The defense will challenge specific causation. In ovarian cancer cases, they will argue the cancer was caused by BRCA mutations, family history, hormone therapy, or other risk factors — not by talc. They will bring epidemiologists who testify that the association between talc and ovarian cancer is weak or inconclusive. They will attack the exposure history: How often did she really use it? For how many years? Can you prove it was J&J powder and not a generic? The counter is built from the exposure documentation (the more detailed and corroborated, the better), the medical history (absence of alternative risk factors strengthens the case), and the epidemiological evidence (studies showing elevated risk in long-term users). A case with a strong exposure history and a clean medical background is hard to attack on causation.
Play 3: The Dose and Duration Challenge
Even when the defense concedes that talc can cause cancer, they will argue that this particular plaintiff did not use enough for long enough. The defense will demand specific quantities: How many times per week? How many years? What dose? This is where the product usage history becomes critical. A family member who can testify “My mother used Johnson’s Baby Powder every single morning after her shower from the time I was a child until she was diagnosed — I saw it every day for thirty years” provides the dose and duration evidence that defeats this defense. The counter to the dose challenge is witness testimony, purchase records where they exist, and the common-knowledge standard: a product marketed for daily use that was used daily for decades provides the exposure the science requires.
Play 4: Procedural Delay
Johnson & Johnson has used the MDL structure, the bankruptcy attempts, and procedural motions to delay resolution of talc cases for years. The MDL itself, while efficient for pretrial matters, can slow individual cases — especially if the MDL court stays individual trials while global settlement negotiations proceed. The counter is to file in state court where possible, where the MDL stay does not apply, and where the right to a jury trial can be exercised on the state’s own docket. The Illinois $45 million verdict is a state-court result — it went to trial and was affirmed without being trapped in the federal MDL’s timeline.
Play 5: The Global Settlement Squeeze
When litigation reaches a certain scale, the defense tries to shift from individual case defense to aggregate resolution — a global settlement that pays every claimant a fraction of what their case is worth individually. The risk to plaintiffs is that a global settlement, while efficient, can undervalue strong cases by averaging them with weak ones. The counter is to know your case’s individual value and to have a lawyer willing to try the case rather than accept a fraction. The $45 million Illinois verdict is proof that individual cases, tried on their own merits, can produce results far beyond what a global settlement framework might offer.
The Proof Story: How a Talc Case Is Actually Built
Here is how a talc case is built, step by step, from the first phone call to the verdict.
Week one: The preservation letter goes out. It goes to Johnson & Johnson (or the appropriate entity), to any relevant third parties, and it demands preservation of all documents related to talc testing, asbestos detection, safety evaluations, marketing materials, and internal communications. It also demands preservation of any product samples, testing records, and manufacturing records relevant to the products the plaintiff used. In a case where the plaintiff has passed, the letter also demands preservation of pathology samples.
Intake and evaluation: The product usage history is documented in detail — brands, frequency, duration, purchase locations, witnesses. The medical records are obtained and reviewed — diagnosis, treatment, pathology, alternative risk factors. The exposure history is correlated with the medical timeline. The question of whether the discovery rule preserves the claim within the statute of limitations is evaluated.
Expert retention: A toxicologist or epidemiologist is retained to address general causation — whether talc exposure can cause the specific cancer type. For mesothelioma cases, a forensic pathologist is retained to address specific causation through tissue analysis. A regulatory or corporate governance expert may be retained to address the willful and wanton conduct standard for punitive damages. For damages, a life-care planner builds the cost of future medical care, and a forensic economist reduces that cost to present value.
Discovery: The case-specific discovery targets J&J’s knowledge timeline, internal testing protocols, and marketing decisions specific to the products the plaintiff used. The MDL document production provides the foundation, but case-specific discovery fills in the gaps. Depositions of corporate witnesses follow — the safety director, the testing scientists, the marketing executives — each explaining the company’s choices under oath.
Trial: In Illinois, trial strategy capitalizes on favorable jury demographics in venues like Cook County while preparing for aggressive defense challenges to specific causation. The jury hears the exposure history, the medical evidence, the internal corporate documents, and the expert testimony. The jury decides whether the company is responsible and what the harm is worth. In Illinois, that jury’s decision is not capped by statute, and as the $45 million affirmance proves, it can survive appellate review.
Your First 72 Hours: What to Do Now
If you or a loved one has been diagnosed with ovarian cancer or mesothelioma and has a history of using talc products, here is what to do — and what not to do — in the first 72 hours.
Do:
-
Document the product usage history immediately. Write down every brand name you can remember — Johnson’s Baby Powder, Shower to Shower, any other talc product. Write down how often it was used (daily, weekly), for how many years, where it was purchased, and who can testify to seeing it used. Do this now, while memories are fresh. If the person who used the product is still alive, have them write it down or record it. If they have passed, gather the family and reconstruct the history together.
-
Preserve any product containers. If there are any bottles, boxes, or containers of talc products still in the home, do not throw them away. Photograph them from every angle, including labels, lot numbers, and any manufacturing codes. Store them safely. The container itself is evidence — it identifies the specific product, and in some cases the lot number can trace the talc to a specific mine or processing facility.
-
Gather the medical records. Obtain copies of all medical records related to the cancer diagnosis and treatment — pathology reports, imaging studies, treatment summaries, physician notes. If the person has passed, request the complete medical record from every treating facility. These records are the foundation of both the injury element and the damages calculation.
-
Identify witnesses. Make a list of every family member, friend, or caregiver who can testify to the product usage. The spouse who shared the bathroom for thirty years. The adult child who remembers the powder on the vanity. The sister who used the same products. Witness testimony is the evidence that cannot be replaced once the witness is gone.
-
Request pathology samples for potential analysis. If your loved one had a biopsy or autopsy, the pathology blocks and slides may still exist at the hospital or medical examiner’s office. For mesothelioma cases, these samples can be analyzed for asbestos fibers using transmission electron microscopy. Contact the pathology department and request that the samples be preserved.
Do NOT:
-
Do not sign anything from any claims administrator or claims program. If you receive a letter offering a settlement or asking you to participate in a claims program, do not sign it without speaking to a lawyer. These documents may contain releases that waive your right to sue.
-
Do not give recorded statements to anyone representing Johnson & Johnson or its insurers. A friendly phone call asking you to “just tell us your story” is a recorded statement engineered to be used against you.
-
Do not post about the case on social media. Defense investigators monitor social media for anything that can be used to challenge the claim — a photo, a comment, a timeline inconsistency.
-
Do not assume it is too late. The discovery rule may preserve your claim even if the exposure was decades ago. The only way to know is to have the specific facts evaluated.
-
Do not wait. Evidence disappears. Witnesses pass away. Product containers get discarded. Pathology samples get destroyed on retention schedules. The preservation letter that freezes those records goes out the day you call a lawyer — and not a day before.
Why This Firm
We are Attorney911 — The Manginello Law Firm, PLLC. We are a trial firm based in Houston, Texas, and we take toxic tort and product liability cases for families across the country, working with local counsel in Illinois where required to bring the full force of our experience to your state’s courts.
Ralph P. Manginello is our Managing Partner — 27+ years of trial practice, admitted to federal court, a journalist before he was a lawyer, and a competitor who hates losing. He built this firm on the principle that the practice of law is a fight for people who cannot fight for themselves, and that a trial lawyer’s job is not to file papers but to stand in front of a jury and make the company answer for what it did. Ralph leads our catastrophic injury and wrongful death practice, and he brings the same intensity to a talc case that he brings to every case that walks through the door.
Lupe Peña is our Associate Attorney — a former insurance-defense attorney who spent years inside a national defense firm, in the rooms where adjusters and their software decided how to deny, delay, and devalue people exactly like you. Lupe knows how the other side values claims — he used to do it. He knows the recorded-statement trap, the IME-doctor selection, the surveillance playbook, and the delay tactics because he ran them. Now he sits on your side of the table, and he conducts full client consultations in Spanish without an interpreter. If your family prays in Spanish, Lupe speaks your language.
We work on contingency. That means we do not get paid unless we win your case. The fee is 33.33% before trial and 40% if the case goes to trial. Your first consultation is free, and it is confidential. You can reach us 24/7 at 1-888-ATTY-911 (1-888-288-9911) — and when you call, you will reach a live person, not an answering service. We have staff available around the clock because the emergencies do not keep business hours.
If you are dealing with a wrongful death from talc-related cancer, we also handle wrongful death claims and understand the specific procedural and emotional dimensions of a case where the person who was hurt is no longer here to tell their own story.
Past results depend on the facts of each case and do not guarantee future outcomes. We do not promise you a specific result. What we promise is that we will tell you the truth about your case, we will fight for every dollar it is worth, and we will not take a dime from you unless we win.
Frequently Asked Questions
How long do I have to file a talc lawsuit in Illinois?
Illinois’s statute of limitations for personal injury claims is generally two years, and the wrongful death limitation is two years from the date of death. However, Illinois applies the discovery rule in toxic tort cases, which means the clock may not start until you knew or reasonably should have known that your injury was connected to talc use. For a disease like ovarian cancer or mesothelioma that can take decades to develop, the discovery rule can mean your claim is still alive even if the exposure ended years ago. The only way to know for certain is to have your specific timeline evaluated by a lawyer familiar with Illinois toxic tort law. Do not assume it is too late — that assumption is exactly what the defense is counting on.
What if I used talc products years ago and just got diagnosed?
This is one of the most common situations in talc litigation. The latency period for talc-related cancers is long — decades, in many cases. A woman who used Johnson’s Baby Powder daily in the 1970s, 1980s, and 1990s may not receive an ovarian cancer diagnosis until the 2020s. The connection between the diagnosis and the exposure may not have been apparent until recently — perhaps you saw a news report about talc litigation, or your doctor mentioned a possible link, or the $45 million verdict headline made you search. Under Illinois’s discovery rule, the date you learned of the connection may be the date the clock starts — not the date you stopped using the product. This is why calling a lawyer promptly after learning of the potential connection matters: the clock may have just started, and you want to make sure it does not run out before you act.
How much is a talc cancer case worth?
There is no single answer because every case turns on its own facts — the severity of the injury, the strength of the exposure history, the presence or absence of alternative risk factors, the venue, and the punitive damages posture. The $45 million verdict upheld by the Illinois Appellate Court is a concrete benchmark for what an Illinois jury can award and what an Illinois appellate court will affirm in a talc case with strong evidence. Cases with similar injury severity, documented exposure, and corporate concealment evidence could command significant settlements or verdicts. Cases with weaker evidence or stronger defense theories will be worth less. An honest evaluation requires reviewing your specific medical records, exposure history, and the available corporate documents — which is why the free consultation exists. You can learn more about how case values are built in this video from Ralph Manginello.
What cancers qualify for a talc lawsuit?
The cancers most consistently linked to talc exposure in the litigation and scientific literature are ovarian cancer (associated with perineal/genital use of talc products) and mesothelioma (associated with inhalation of asbestos-contaminated talc). Other cancers, including endometrial cancer and certain respiratory cancers, have been studied but have less established causal connections. The question of whether your specific diagnosis supports a viable claim depends on the strength of the scientific evidence for that cancer type, your individual exposure history, and the medical evidence in your case. Not every cancer is talc-related — but if you have ovarian cancer or mesothelioma and a history of talc product use, the connection is worth evaluating.
Can I still file if Johnson & Johnson filed for bankruptcy?
Johnson & Johnson’s bankruptcy strategy has failed three times. The company created entities (LTL Management LLC, then Red River Talc LLC) to channel talc liability into bankruptcy, and each attempt was dismissed by the courts — most recently on March 31, 2025, when the U.S. Bankruptcy Court for the Southern District of Texas dismissed the third attempt. The talc cases are back in the regular court system, the tort system, where juries decide what the harm is worth. You can still file a talc lawsuit. The bankruptcy attempts delayed cases but did not eliminate them. If anything, each failed bankruptcy attempt is evidence of a company trying to avoid jury accountability — which is itself a piece of the story a jury can hear.
What evidence do I need for a talc case?
The four categories of evidence that build a talc case are: (1) your product usage history — the brands, frequency, duration, and witnesses who can confirm the use; (2) your medical records — diagnosis, pathology, treatment, and assessment of alternative risk factors; (3) internal Johnson & Johnson corporate documents — testing, asbestos detection, safety evaluations, and marketing decisions (much of this is already produced in the national MDL and available to your case); and (4) for mesothelioma cases, pathology and tissue analysis showing asbestos fibers consistent with talc product exposure. You do not need to gather all of this yourself — that is what the legal process does. But the one piece you can and should secure immediately is the product usage history, because that is the evidence most likely to fade with time.
Does Illinois cap damages in product liability cases?
No. Illinois does not impose statutory caps on compensatory or punitive damages in product liability actions. Illinois courts have historically struck down damage cap legislation on constitutional grounds. This means a jury in Illinois can award the full amount of compensatory damages (medical costs, lost earnings, pain and suffering, loss of society) and the full amount of punitive damages (where willful and wanton conduct is proven by clear and convincing evidence) — and those awards are not reduced by statute. The $45 million verdict upheld by the Illinois Appellate Court is an example of what an uncapped system produces: the jury’s full judgment, affirmed without reduction.
What if my loved one died from talc-related cancer?
If your loved one has died from ovarian cancer or mesothelioma linked to talc exposure, Illinois law provides two parallel paths. A survival action belongs to the estate and recovers the damages the decedent would have been able to claim — medical expenses incurred before death, pain and suffering experienced, and lost earnings during the period between injury and death. A wrongful death action belongs to the surviving family members and recovers for their losses — the financial support the decedent would have provided, the loss of society and companionship, and the grief of the family. Illinois treats these as distinct damage categories, and a complete case pursues both. The personal representative of the estate is the person authorized to bring the claim, and we handle that appointment as part of the process. The two-year statute of limitations for wrongful death runs from the date of death, so time is a critical factor.
How long does a talc lawsuit take?
Talc cases are complex mass tort cases, and the timeline depends on whether the case is filed in state court or in the federal MDL, the complexity of the individual facts, the volume of discovery, and the court’s docket. Cases filed in the MDL may move through pretrial proceedings more efficiently because of the consolidated discovery, but individual trial dates depend on the MDL court’s bellwether selection process. Cases filed in Illinois state court may reach trial faster because they are not subject to the MDL’s scheduling, but they still involve extensive discovery and expert preparation. A realistic timeline from filing to trial is measured in years, not months — though settlement can occur at any point if the defense determines that the case’s value justifies resolution. The $45 million Illinois verdict was a state-court result, which means it went through the state court system on its own timeline, not the MDL’s.
Do I have to go to the federal MDL or can I file in Illinois state court?
You may be able to file in Illinois state court, which is what happened with the $45 million verdict that was just upheld. The federal MDL (MDL-2738, in the District of New Jersey) is a consolidation of federal cases for pretrial proceedings — it is not a class action, and each plaintiff retains an individual claim. If you file in state court and the defendant cannot remove the case to federal court, your case stays in state court and proceeds on the state court’s docket. There are strategic considerations to both paths — the MDL offers efficiencies in document discovery and expert work, while state court may offer a faster path to trial and a more favorable jury pool. The right choice depends on your specific circumstances, and it is one of the first strategic decisions made in your case.
Your Next Step
The $45 million verdict that just survived appeal in Illinois is proof that the system can work — that a jury can hear the evidence, hold a corporation accountable, and that an appellate court will let that accountability stand. But that proof is only meaningful to you if you act on it. The evidence that connects your family to this story — the product usage history, the medical records, the witness testimony — is the evidence that fades with every passing day. The preservation letter that freezes those records goes out the day you call a lawyer, and not a day before.
Call us at 1-888-ATTY-911 (1-888-288-9911). The consultation is free. The call is confidential. You will speak to a live person, not a machine, and you will get straight answers about whether you have a case, what it might be worth, and how long you have to decide. If we are not the right fit for your situation, we will tell you — and we will point you to someone who is.
We do not get paid unless we win your case. That means the consultation costs you nothing, and the case costs you nothing unless there is a recovery. The only thing it costs you to find out the truth is a phone call.
Hablamos Español. Lupe Peña conducts full consultations in Spanish — without an interpreter, without a language barrier, without anything lost in translation. If your family communicates in Spanish, so do we.
Contact us today. The evidence is waiting. The clock is running. And the door that the Illinois Appellate Court just held open — the door that lets a jury decide what your family’s harm is worth — will not stay open forever.
Past results depend on the facts of each case and do not guarantee future outcomes. This page is legal information, not legal advice. Contacting the firm is free and confidential.